Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Jennifer S. Michaelson"'
Autor:
Karsten Sauer, Kavya Rakhra, Kaida Wu, Naveen K. Mehta, Jennifer S. Michaelson, Patrick A. Baeuerle
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
As powerful activators of the immune system, cytokines have been extensively explored for treating various cancers. But despite encouraging advances and some drug approvals, the broad adoption of cytokine therapies in the clinic has been limited by l
Externí odkaz:
https://doaj.org/article/550bf70a3b514b3d9c6753f13cfe79e3
Autor:
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, Alexander Steinle, Jennifer S. Michaelson, Patrick A. Baeuerle
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTThe field of immuno-oncology has revolutionized cancer patient care and improved survival and quality of life for patients. Much of the focus in the field has been on exploiting the power of the adaptive immune response through therapeutic ta
Externí odkaz:
https://doaj.org/article/fb972df6cd544835ae785a6f2c34f6d4
Autor:
Melanie Märklin, Gundram Jung, Jonas S Heitmann, Joseph Kauer, Helmut R Salih, Stefanie Mueller, Bochong Li, Latifa Zekri, Naveen K Mehta, Martin Pfluegler, Kristan Meetze, Isabelle Sindel, Fabian Vogt, Lukas Osburg, Hans-Jörg Bühring, Sebastian Hörner, Patrick A Baeuerle, Jennifer S Michaelson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)
Background In lymphoid malignancies, the introduction of chimeric antigen receptor T (CAR-T) cells and bispecific antibodies (bsAbs) has achieved remarkable clinical success. However, such immunotherapeutic strategies are not yet established for acut
Externí odkaz:
https://doaj.org/article/3b2e9606c0a24dee884cff6451dd74fe
Autor:
Michael E. Berens, Luigi Mariani, Joseph C. Loftus, Christopher A. Lipinski, Linda C. Burkly, Jennifer S. Michaelson, Jessica L. Rennert, Dominique B. Hoelzinger, Galen Hostetter, Heather E. Cunliffe, Mitsutoshi Nakada, Marc Symons, Jeffrey A. Winkles, Shannon P. Fortin, Benjamin A. Savitch, Wendy S. McDonough, Nhan L. Tran
Supplementary Data 3 from Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6915f6c85c6bd2a4ed267017dd609b4
https://doi.org/10.1158/0008-5472.22364594
https://doi.org/10.1158/0008-5472.22364594
Autor:
Michael E. Berens, Luigi Mariani, Joseph C. Loftus, Christopher A. Lipinski, Linda C. Burkly, Jennifer S. Michaelson, Jessica L. Rennert, Dominique B. Hoelzinger, Galen Hostetter, Heather E. Cunliffe, Mitsutoshi Nakada, Marc Symons, Jeffrey A. Winkles, Shannon P. Fortin, Benjamin A. Savitch, Wendy S. McDonough, Nhan L. Tran
Supplementary Data 1 from Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12dffbea7b9f6f6a11242d752a52b524
https://doi.org/10.1158/0008-5472.22364600
https://doi.org/10.1158/0008-5472.22364600
Autor:
Michael E. Berens, Luigi Mariani, Joseph C. Loftus, Christopher A. Lipinski, Linda C. Burkly, Jennifer S. Michaelson, Jessica L. Rennert, Dominique B. Hoelzinger, Galen Hostetter, Heather E. Cunliffe, Mitsutoshi Nakada, Marc Symons, Jeffrey A. Winkles, Shannon P. Fortin, Benjamin A. Savitch, Wendy S. McDonough, Nhan L. Tran
Supplementary Data 2 from Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939ce600e6dd0d05bc942a40c400714f
https://doi.org/10.1158/0008-5472.22364597.v1
https://doi.org/10.1158/0008-5472.22364597.v1
Autor:
Michael E. Berens, Luigi Mariani, Joseph C. Loftus, Christopher A. Lipinski, Linda C. Burkly, Jennifer S. Michaelson, Jessica L. Rennert, Dominique B. Hoelzinger, Galen Hostetter, Heather E. Cunliffe, Mitsutoshi Nakada, Marc Symons, Jeffrey A. Winkles, Shannon P. Fortin, Benjamin A. Savitch, Wendy S. McDonough, Nhan L. Tran
Supplementary Data 4 from Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceedd0c71efdff09665a8991c86262f2
https://doi.org/10.1158/0008-5472.22364591
https://doi.org/10.1158/0008-5472.22364591
Autor:
Michael E. Berens, Luigi Mariani, Joseph C. Loftus, Christopher A. Lipinski, Linda C. Burkly, Jennifer S. Michaelson, Jessica L. Rennert, Dominique B. Hoelzinger, Galen Hostetter, Heather E. Cunliffe, Mitsutoshi Nakada, Marc Symons, Jeffrey A. Winkles, Shannon P. Fortin, Benjamin A. Savitch, Wendy S. McDonough, Nhan L. Tran
Glial tumors progress to malignant grades by heightened proliferation and relentless dispersion throughout the central nervous system. Understanding genetic and biochemical processes that foster these behaviors is likely to reveal specific and effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af62b383f3797b4873c67b0b44884f34
https://doi.org/10.1158/0008-5472.c.6494267.v1
https://doi.org/10.1158/0008-5472.c.6494267.v1
Autor:
Kerry A. Whalen, Naveen K. Mehta, Kristan Meetze, Jennifer S. Michaelson, Patrick S. Baeuerle
Publikováno v:
Cancer Research. 83:2943-2943
CLN-619 is a humanized IgG1 monoclonal antibody, currently in phase 1 clinical development in cancer patients, that targets the NKG2D ligands MICA and MICB. Both ligands serve as activating signals for NKG2D on NK cells and a subset of T cell populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d196c321e227369514931bdd7395b5c
https://doi.org/10.1158/1538-7445.am2023-2943
https://doi.org/10.1158/1538-7445.am2023-2943
Publikováno v:
Cancer Research. 82:2077-2077
T cell therapies targeting the B cell antigen CD19 have profoundly changed the way we treat various B cell malignancies. Both the CD19-specific T cell-engaging bispecific antibody blinatumomab and various autologous CAR-T cell therapies have exhibite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5274ea10a42305938f464d2a210fe1bb
https://doi.org/10.1158/1538-7445.am2022-2077
https://doi.org/10.1158/1538-7445.am2022-2077